TY  - JOUR
AU  - Ruiz-Leon, B
AU  - Navas, A
AU  - Serrano, P
AU  - Espinazo, M
AU  - Labrador-Horrillo, M
AU  - Monsalve, R I
AU  - Jurado, A
AU  - Moreno-Aguilar, C
PY  - 2020
DO  - 10.18176/jiaci.0498
SN  - 1018-9068
UR  - http://hdl.handle.net/10668/15163
T2  - Journal of investigational allergology & clinical immunology
AB  - Bee venom immunotherapy (BVIT), although highly effective, does not protect 10%-15% of patients allergic to bee stings [1]. Even though the production of allergenic extracts is standardized, the real content of major components is not completely...
LA  - en
PB  - Esmon Publicidad
KW  - Api m 10
KW  - Bee venom allergy
KW  - Effectiveness of venom immunotherapy
KW  - Molecular diagnosis
KW  - Allergens
KW  - Basophil Degranulation Test
KW  - Bee Venoms
KW  - Beekeeping
KW  - Desensitization, Immunologic
KW  - Humans
KW  - Hypersensitivity
KW  - Immune Tolerance
KW  - Immunization
KW  - Immunoglobulin E
KW  - Insect Bites and Stings
KW  - Male
KW  - Middle Aged
KW  - Occupational Exposure
TI  - Successful Adaptation of Bee Venom Immunotherapy in a Patient Monosensitized to Api m 10.
TY  - research article
VL  - 30
ER  -